Patient Education — BPH Treatment Options

Understanding Your Prostate Treatment Options

Benign prostatic hyperplasia (BPH) affects millions of men and has many treatment paths. This guide gives you honest, up-to-date information on every major surgical and minimally invasive option — so you can make a truly informed decision alongside Dr. Childs.

Dr. Childs offers HoLEP, TURP, Optilume for BPH, and UroLift removal. Our practice also coordinates access to Aquablation, Rezūm, GreenLight, and PAE — because every patient deserves the right option, not just the one any single surgeon performs.

Jump to a procedure

At a Glance

BPH Procedures Compared

The table below summarizes the key differences. Green indicates an advantage; amber indicates acceptable; red indicates a limitation. HoLEP's combination of durability, size-independence, and complete tissue removal makes it uniquely suited as a permanent solution.

Metric HoLEP TURP RSP Aquablation GreenLight UroLift Rezūm PAE
Tissue Removed Complete Partial Complete Partial Vaporized (partial) None None (ablated) None
Works for Any Prostate Size Yes <80cc ideal Yes (large glands) 30–150cc <100cc ideal ≤100cc only ≤80cc Most sizes
Retreatment Rate <1–2% at 10 yrs 10–15% at 10 yrs 5–10% ~5% at 5 yrs 10–20% at 5 yrs 14–20% at 5–8 yrs ~10% at 5 yrs 20–30% at 3–5 yrs
Hospital Stay Same day* 1–2 days 2–3 days Overnight typical Same day–overnight Outpatient Outpatient Outpatient
Catheter Duration Same day removal* 2–4 days 7–14 days 1–3 days 1–3 days Hours 3–7 days 3–5 days
Ejaculatory Function Preserved Retrograde ejac. common Usually not Usually not Better than TURP Often retrograde Yes Usually yes Usually yes
Erectile Function Risk Very low Low–moderate Low–moderate Very low Very low Minimal Minimal Low
Blood Loss / Transfusion Risk Minimal Moderate Higher Moderate (cautery needed) Low–moderate Minimal Minimal Minimal
Safe on Blood Thinners Yes Requires stopping Requires stopping Usually Requires stopping Yes Usually Yes
Tissue for Pathology Yes — cancer screening Yes Yes No No No No No
Insurance Coverage Yes (Medicare & most) Universal Most plans Limited (T-code) Most plans Most plans Most plans Varies
AUA Guidelines Endorsement Strongly recommended Recommended Recommended (large) Conditional Conditional Conditional Conditional Conditional

* Same-day discharge and catheter removal achieved by Dr. Childs for most patients — an advanced approach beyond standard practice.

Gold Standard

HoLEP — Holmium Laser Enucleation of the Prostate

HoLEP is widely regarded by the American Urological Association (AUA) and the European Association of Urology (EAU) as the highest-efficacy, lowest-retreatment surgical option for BPH. It is the only size-independent procedure that completely removes the obstructing tissue using laser precision, with no incisions required.

How It Works

A high-powered holmium laser is passed through the urethra via a resectoscope. The laser precisely enucleates (peels away) the entire adenomatous tissue of the prostate from its surgical capsule — like removing a walnut from its shell. The tissue is then morcellated into fragments inside the bladder and removed. No skin incisions are ever made.

Dr. Childs employs the en bloc technique with early apical release, a cutting-edge refinement that maximizes precision at the apex and optimizes continence outcomes.

Why It's the Gold Standard
  • <1% retreatment rate at 10 years — far superior to all alternatives
  • Works for any prostate size — no upper volume limit
  • Tissue sent to pathology — incidental prostate cancer detected
  • Safe on blood thinners — no need to stop anticoagulants
  • Same-day discharge and catheter removal (Dr. Childs's approach)
  • Endorsed by AUA and EAU as highest-evidence surgical option
  • Salvages failed prior procedures (TURP, UroLift, GreenLight)
Dr. Childs's Practice
High-volume HoLEP specialist — this is his primary focus
Schedule HoLEP Consultation

Traditional Surgery

TURP — Transurethral Resection of the Prostate

TURP has been the most commonly performed BPH surgery for decades and remains widely available. A resectoscope loop shaves away prostate tissue piece by piece. While effective, it removes only partial tissue, carries a meaningful retreatment rate over time, and is less favorable for large prostates or patients on blood thinners.

Advantages
  • Widely available and well-understood
  • Universal insurance coverage
  • Tissue sent to pathology
  • Strong symptom improvement
Limitations
  • 10–15% retreatment rate at 10 years
  • Risk of TUR syndrome (fluid absorption)
  • Blood loss requiring transfusion in some cases
  • Ejaculation often permanently affected
  • Not ideal for very large prostates (>80cc)
  • Requires stopping blood thinners
✓ Dr. Childs offers TURP for appropriate patients who prefer or require it

Robot-Assisted Surgery

RSP — Robot-Assisted Simple Prostatectomy

RSP uses a robotic surgical system to remove the inner portion of the prostate through small abdominal incisions. It is typically reserved for very large prostates (>100–150cc) where endoscopic options are more technically challenging. When compared directly to HoLEP, RSP has been shown to result in longer hospital stays, higher blood loss, and more complications, while HoLEP achieves equivalent or superior outcomes with no external incisions.

Advantages
  • Effective for very large prostates
  • Robotic precision
  • Tissue available for pathology
Limitations vs. HoLEP
  • Requires abdominal incisions — scarring
  • Longer hospital stay (2–3 days)
  • Higher blood loss and transfusion risk
  • Longer catheter duration (7–14 days)
  • More post-op complications than HoLEP in studies
  • Generally not preferred when HoLEP is available

Laser Vaporization

GreenLight Laser — Photoselective Vaporization of the Prostate (PVP)

GreenLight laser therapy uses a high-powered green laser to vaporize prostate tissue, opening the urinary channel without cutting or removing the gland. It has been used for many years and is widely available. While it is less invasive than TURP with lower blood loss, it has significant drawbacks compared to HoLEP — particularly around tissue removal completeness, long-term durability, and post-operative irritative voiding symptoms.

Advantages
  • Lower blood loss than TURP
  • Can be done safely on blood thinners in some cases
  • Widely available at most urology centers
  • Same-day or overnight procedure
  • Good short-term symptom improvement
Limitations — Why Dr. Childs Prefers HoLEP
  • Tissue is vaporized, not removed — no pathology specimen, no cancer detection
  • Incomplete tissue removal leads to prostate regrowth over time
  • Retreatment rates of 10–20% at 5 years — significantly worse than HoLEP
  • Not size-independent — less effective for very large prostates
  • Post-operative irritative voiding symptoms (urgency, burning, frequency) are common and often prolonged — sometimes lasting weeks to months
  • Sloughing of vaporized tissue can cause blockage and urinary retention requiring re-catheterization
  • Symptom durability inferior to HoLEP at 5–10 year follow-up
Dr. Childs's Position: GreenLight laser vaporization had its era of popularity, but it has been largely surpassed by HoLEP in terms of durability and completeness of tissue removal. The irritative voiding symptoms patients experience post-operatively — burning, urgency, and frequency — are a common complaint and can be quite disruptive for weeks after surgery. Because tissue is vaporized rather than collected, there is also no opportunity to screen for incidental prostate cancer. For patients who are surgical candidates, Dr. Childs consistently recommends HoLEP as the superior and more durable alternative.

Robotic Water Jet

Aquablation — Robotic Water Jet Ablation

Aquablation uses a high-pressure, robotically-guided water jet to ablate prostate tissue, guided by real-time ultrasound imaging. It has grown in popularity due to its ejaculatory function preservation advantage and shorter learning curve than HoLEP. Symptom improvement is comparable to TURP and HoLEP, but the long-term retreatment durability data still lag behind HoLEP. Aquablation requires a separate electrocautery step for hemostasis, typically an overnight hospital stay, and a catheter for 1–3 days. It currently has limited insurance coverage in the United States.

Advantages
  • Better ejaculatory preservation than TURP or HoLEP
  • Shorter learning curve than HoLEP
  • Effective for prostates 30–150cc
  • Good symptom score improvement
  • Robotic precision reduces surgeon variability
Limitations
  • No tissue sent for pathology — no cancer screening benefit
  • Requires separate cautery step for bleeding control
  • Overnight hospital stay typical
  • Catheter required 1–3 days post-procedure
  • Limited insurance coverage (T-code billing)
  • Higher hospital readmission than HoLEP in some studies
  • Long-term retreatment data not as robust as HoLEP
A note from Dr. Childs: Aquablation is a legitimate option for the right patient — particularly men with medium-to-large prostates who strongly prioritize ejaculatory preservation. Our practice is committed to ensuring every patient has access to the full range of BPH treatments. If Aquablation appears to be the best fit for your situation, Dr. Childs will make sure you are connected with the appropriate expertise within our network to pursue that path.

Minimally Invasive Surgical Therapies

MIST Procedures — Office-Based Options

MIST procedures offer outpatient convenience and sexual function preservation, but they do not remove prostate tissue. This means symptoms may return, retreatment rates are meaningfully higher than surgical options, and they are not suitable for all prostate sizes or anatomies. They are best considered for younger men wishing to preserve ejaculatory function, men with smaller prostates, or those who are poor surgical candidates.

Dr. Childs is NOT a Proponent
UroLift
Prostatic Urethral Lift System
Outpatient 14–20% retreatment at 5–8 yrs ≤100cc only
UroLift places permanent metal implants that mechanically retract the prostate lobes, opening the urethral channel without removing any tissue. It preserves ejaculatory and erectile function and has a fast recovery. However, Dr. Childs does not recommend UroLift as a preferred treatment because the implants often fail over time, with retreatment rates reaching 14–20% by 5–8 years in real-world data. The permanent implants can also complicate future procedures, cause discomfort, or erode over time. For these reasons, Dr. Childs offers UroLift removal as a service for patients who have had UroLift and experienced failure or complications, often proceeding to HoLEP as a definitive solution.
Dr. Childs's Position: UroLift is a temporary measure, not a cure. The permanent implants remain in the prostate after failure and must be removed before further surgery can be performed. Dr. Childs offers UroLift removal for patients who have had an unsuccessful UroLift procedure and are ready for a definitive solution.
MIST
Rezūm
Water Vapor Thermal Therapy
Outpatient ~10% retreatment at 5 yrs ≤80cc prostate
Rezūm delivers bursts of water vapor (steam) into prostate tissue, causing cellular death through thermal energy. Over 3–6 weeks, the destroyed tissue is gradually absorbed, reducing prostate volume and relieving obstruction. It preserves sexual function in most patients and is performed in an outpatient setting with no general anesthesia required. Retreatment rates are approximately 10% at 5 years — better than UroLift but not comparable to HoLEP. A urinary catheter is required for several days post-procedure while tissue reabsorption begins. Not suitable for very large prostates or certain anatomies. No tissue is available for pathology.
Our approach: Rezūm is a reasonable option for carefully selected patients — particularly men with smaller prostates who are not surgical candidates or who strongly wish to avoid any form of surgery. Dr. Childs discusses Rezūm openly with appropriate patients and ensures those who are best suited for it have access to the procedure through our broader network of urology specialists.
MIST — Newer Technology
Optilume for BPH
Drug-Coated Balloon Dilation
Outpatient Emerging Data No Tissue Removed
Optilume for BPH is a newer FDA-cleared technology that uses a drug-coated balloon to dilate the prostatic urethra. The balloon is coated with paclitaxel, an anti-proliferative agent, which is designed to inhibit re-narrowing of the treated area after dilation. The procedure is minimally invasive, preserves sexual function, and is performed outpatient. Long-term data are still emerging — it appears promising for smaller prostates and patients prioritizing sexual function preservation. Dr. Childs stays at the forefront of this emerging option and offers it for carefully selected patients.
✓ Dr. Childs offers Optilume for BPH for appropriate patients

The Most Non-Invasive Option Available

Prostate Artery Embolization (PAE)

No surgery. No general anesthesia. No hospital stay. Just a tiny needle puncture — and a prostate that starts shrinking.

PAE is performed not in an operating room, but by an interventional radiologist — a specialist who treats conditions through tiny catheters guided by imaging. Here is how it works in plain language: a small needle — about the size of an IV line — is inserted into your wrist or groin. Through that tiny opening, a thin flexible tube is guided through your arteries to the blood vessels feeding your prostate. Tiny microspheres (microscopic beads) are then injected, blocking part of the blood supply. Over the next 4–8 weeks, your prostate gradually shrinks as the tissue softens, relieving the obstruction and improving your urinary symptoms.

You go home the same day. Most men return to normal activity within a few days. There are no cuts, no stitches, and no catheter in most cases. Ejaculatory and erectile function are preserved in the vast majority of patients.

PAE is an excellent option for men who want real symptom relief without undergoing surgery — or for those whose health makes surgery a higher risk. Dr. Childs actively discusses PAE with all appropriate patients and works directly with a dedicated PAE clinic through Granger Medical — Summit Urology, ensuring a seamless referral to a specialized team experienced in this procedure.

Our PAE Partnership

PAE is available through our affiliated Granger Medical — Summit Urology PAE Clinic. Dr. Childs coordinates care directly with the interventional radiology team, so your evaluation, procedure, and any follow-up care are all managed under one roof — a true prostate center of excellence.

Who Is PAE Right For?
Men who want relief from BPH without any surgery or general anesthesia
Patients with serious health conditions that make surgery a higher risk (heart disease, lung disease, obesity)
Men on blood thinners who cannot safely stop them for surgery
Men wishing to fully preserve ejaculatory and sexual function
Men who have had prior BPH surgery and are not candidates for repeat surgery
Those seeking the absolute minimum disruption to work and daily life
What to Keep in Mind
The prostate is not removed — symptoms can return over time as it regrows
Symptom improvement is meaningful but generally less dramatic than HoLEP or TURP
Some men experience a few days of mild flu-like symptoms (fever, fatigue) after the procedure as the body responds — this is normal and temporary
Retreatment is more likely over 5–10 years compared to surgical options
Insurance coverage varies — we help you verify this before your appointment

Dr. Childs's Perspective

Why HoLEP is the Preferred Choice

"For most men with BPH who are surgical candidates, HoLEP offers something no other procedure can: permanent, durable relief with the lowest retreatment rate in urology."

No two patients are identical, and Dr. Childs believes every man deserves a thorough consultation where all options are laid out honestly — including their limitations. That said, the evidence is clear: for men who are surgical candidates, HoLEP consistently outperforms every alternative on the most important metric: long-term durability.

GreenLight laser vaporization — once widely popular — has fallen behind HoLEP in every meaningful outcome category: retreatment rates, tissue removal completeness, and post-operative irritative symptoms. MIST procedures like UroLift and Rezūm offer convenience, but trade durability for that convenience — men often find themselves back in the office within 5–8 years, sometimes having made their next procedure more complicated.

Dr. Childs performs a high volume of HoLEP procedures and is committed to ensuring every patient can access the full spectrum of BPH care — whether that means performing HoLEP himself, coordinating with our network for Aquablation or Rezūm, or arranging a PAE evaluation through our affiliated clinic. You will never be turned away because we only do one thing.

01
Unmatched durability
Less than 1–2% retreatment rate at 10 years. No other BPH procedure comes close to this benchmark.
02
Size doesn't matter
HoLEP works equally well for 40cc and 250cc prostates. Most other options have strict size limits.
03
Cancer detection
Because tissue is sent to pathology, incidental prostate cancer is detected in a meaningful percentage of HoLEP patients — a benefit no MIST or ablative procedure can offer.
04
Safe on anticoagulants
Unlike TURP, patients on warfarin, Eliquis, or Xarelto can undergo HoLEP safely without stopping their medications.
05
Endorsed by every major guideline
The AUA, EAU, and CUA all give HoLEP the strongest recommendation of any endoscopic BPH procedure.

Next Step

Ready to Discuss Your Options?

Dr. Childs will take the time to review your specific anatomy, symptoms, and goals — and give you his honest recommendation. Most patients are seen within 1–2 weeks.